Other Therapeutic Indications

In addition to all the major GI indications, an intravenous formulation and a single use oral solution formulation can be developed for the growing and important unmet needs in ICU and ventilator units of Enteral Feeding Intolerance (EFI), acute GP, short bowel syndrome (SBS), and post-operative ileus (POI). There are currently no FDA-approved treatment options available for these indications which impact several million people, with EFI alone affecting one million Americans.